Knight to Present at the National Bank Financial Quebec Conference in Toronto
May 25 2018 - 8:00AM
Knight Therapeutics Inc. (TSX:GUD), a leading Canadian specialty
pharmaceutical company, announced today that Samira Sakhia,
President and Chief Financial Officer, is scheduled to present a
corporate update at the National Bank Financial 8th Annual Quebec
Conference on Wednesday, May 30, 2018 at 1:30 pm ET at Shangri-La
Hotel in Toronto. A copy of the presentation will be available at
www.gudknight.com.
About Knight Therapeutics Inc.
Knight Therapeutics Inc., headquartered in Montreal, Canada, is
a specialty pharmaceutical company focused on acquiring or
in-licensing innovative pharmaceutical products for the Canadian
and select international markets. Knight Therapeutics Inc.'s shares
trade on TSX under the symbol GUD. For more information about
Knight Therapeutics Inc., please visit the company's web site at
www.gudknight.com or www.sedar.com.
Forward-Looking Statement
This document contains forward-looking statements for Knight
Therapeutics Inc. and its subsidiaries. These forward-looking
statements, by their nature, necessarily involve risks and
uncertainties that could cause actual results to differ materially
from those contemplated by the forward-looking statements. Knight
Therapeutics Inc. considers the assumptions on which these
forward-looking statements are based to be reasonable at the time
they were prepared, but cautions the reader that these assumptions
regarding future events, many of which are beyond the control of
Knight Therapeutics Inc. and its subsidiaries, may ultimately prove
to be incorrect. Factors and risks, which could cause actual
results to differ materially from current expectations are
discussed in Knight Therapeutics Inc.'s Annual Report and in Knight
Therapeutics Inc.'s Annual Information Form for the year ended
December 31, 2017. Knight Therapeutics Inc. disclaims any intention
or obligation to update or revise any forward-looking statements
whether as a result of new information or future events, except as
required by law.
CONTACT INFORMATION:
Knight Therapeutics Inc. Samira Sakhia President & Chief
Financial Officer T: 514-678-8930 F: 514-481-4116
info@gudknight.com www.gudknight.com
Knight Therapeutics (TSX:GUD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Knight Therapeutics (TSX:GUD)
Historical Stock Chart
From Sep 2023 to Sep 2024